Mearin M Luisa, Catassi Carlo, Brousse Nicole, Brand Ronald, Collin Pekka, Fabiani Elisabetta, Schweizer Joachim J, Abuzakouk Mohamed, Szajewska Hania, Hallert Claes, Farré Masip Carme, Holmes Geoffrey K T
Department of Paediatrics, Leiden University Medical Center, Leiden, The Netherlands.
Eur J Gastroenterol Hepatol. 2006 Feb;18(2):187-94. doi: 10.1097/00042737-200602000-00012.
Coeliac disease (CD) is associated with an increased risk of non-Hodgkin lymphoma (NHL), but there is little information about whether this is true for clinically silent CD.
To investigate the frequency of CD in two European populations; one with NHL and another derived from the general population.
A prospective, multi-centre, case-control study in 10 European countries was conducted between May 1998 and April 2001. A total of 1446 consecutive patients with newly diagnosed NHL aged over 18 years was collected. The control group consisted of a population of 9676 individuals who were screened for CD. The number of patients with a previous diagnosis of CD and those with silent CD detected by screening were determined in the two groups.
The patients with CD had a significantly increased risk of developing NHL [odds ratio (OR) 2.6, 95% confidence interval (CI) 1.4-4.9]. This risk was only present in patients with CD diagnosed clinically before the study (OR 3.3, 95% CI 1.4-7.9), but not in those with silent CD detected by screening (OR 1.3, 95% CI 0.6-2.7).
Patients with CD have an increased risk of developing NHL, although this is lower than previously thought. Clinically silent CD is rare in patients with NHL.
乳糜泻(CD)与非霍奇金淋巴瘤(NHL)风险增加相关,但对于临床无症状的CD是否如此,相关信息甚少。
调查两个欧洲人群中CD的发生率;一组为NHL患者,另一组来自普通人群。
1998年5月至2001年4月在10个欧洲国家开展了一项前瞻性、多中心病例对照研究。共收集了1446例年龄超过18岁、新诊断为NHL的连续患者。对照组由9676名接受CD筛查的个体组成。确定两组中既往诊断为CD的患者数量以及筛查发现的无症状CD患者数量。
CD患者发生NHL的风险显著增加[比值比(OR)2.6,95%置信区间(CI)1.4 - 4.9]。这种风险仅存在于研究前临床诊断为CD的患者中(OR 3.3,95% CI 1.4 - 7.9),而筛查发现的无症状CD患者中不存在(OR 1.3,95% CI 0.6 - 2.7)。
CD患者发生NHL的风险增加,尽管低于先前的认知。临床上无症状的CD在NHL患者中罕见。